Vaccination has proved to be a blessing to mankind in eradicating many bacterial, viral, fungal and other uncountable diseases. And medical scientists may finally have developed a vaccine for Alzheimer’s disease, a serious auto immune disorder that has proved to be fatal to thousands.
The scholars and researchers at the university of Texas Southwestern Medical Center in Dallas have stated that a vaccine developed against Alzheimer’s is showing good results. For now, the testings are conducted on mice and before conducting actual human tests, the vaccine is further tested through on other vertebrates to study the effect of vaccine. Although the results have turned out to be good enough in animal trials, it was thought to be a long journey for these trials to be carried out with humans.
However, a recent publication in the journal Alzheimer’s Research & Therapy, it was stated that if the vaccine is proven safe and effective and if human trials turn out to be safe, it could reduce the total number of dementia diagnoses in half. Alzheimer’s is one of the major diseases causing dementia, a severe decline in cognitive abilities, loss of cognitive capabilities and other mental illnesses in patients and the disease progresses further. So the vaccine can prove to be beneficial to curb this immense trauma one has to go through due to Alzheimer’s.
The mechanism of vaccine targets two proteins that are responsible for degenerative disorder in the body. Two abnormal protein structures called plaques and tangles can build up in the brain and disrupt nerve cells. The new vaccine may be able to stop such a build-up of these proteins without causing autoimmune inflammation, the researchers wrote. It doesn’t cause brain inflammation like previous vaccines and is tested to be safe on rabbits and monkeys till now.
This vaccine, hence is totally capable of granting longer and healthier lives to people and eliminate the brain degenerative disorder from entire gene pools. As one of the scientists said, “If the onset of the disease could be delayed by even five years, that would be enormous for the patients and their families. The number of dementia cases could drop by half.”